ArticleJournal of cancer research and clinical oncology2024

Molecular docking and MD simulation studies of 4-thiazol-N-(pyridin-2-yl)pyrimidin-2-amine derivatives as novel inhibitors targeted to CDK2/4/6.

Jia-Dong Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.